Dennis J. Slamon, M.D., Ph.D., serves as director of Clinical/Translational Research, and as director of the Revlon/UCLA Women's Cancer Research Program at JCCC. He is a professor of medicine, chief of the Division of Hematology/Oncology and executive vice chair for research for UCLA's Department of Medicine. Slamon also serves as director of the medical advisory board for the National Colorectal Cancer Research Alliance, a fund-raising organization that promotes advances in colorectal cancer. For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients. To acknowledge Slamon's accomplishments, President Clinton appointed Slamon to the three-member President's Cancer Panel in June 2000. A 1975 honors graduate of the University of Chicago's Pritzker School of Medicine, Slamon earned his Ph.D. in cell biology that same year. He completed his internship and residency at the University of Chicago Hospitals and Clinics, becoming chief resident in 1978. One year later, he became a fellow in the Division of Hematology/Oncology at UCLA.
View More
Education Background
RESIDENCY
Ucla Medical Center
MEDICAL SCHOOL
Univ Of Chicago Division Of Biological Sciences Pritzker School Of Medicine - 1975
Languages Spoken
Spanish
Russian
Location & Hours
Ucla Santa Monica Parkside
2336 Santa Monica Blvd Ste 304, Santa Monica, CA 90404
Specialties Treated
Oncology
Obstetrics & Gynecology
Gynecologic Oncology
Conditions Addressed
Venous Embolism and Thrombosis
Malignant Neoplasm of Colon
Leukemia
Non-Hodgkin's Lymphoma
Malignant Neoplasm of Female Breast
View More
Procedures Performed
Chemotherapy
Insurance Accepted
* Insurance information may change frequently. Please verify directly with the provider (doctor/clinic).